Further, immune checkpoint ligand PDL1 is upregulated in EMT-activated human breast cancer cells [92] and was shown to be more highly expressed in metastatic CRC than in primary CRC [93], suggesting its correlation with stem cell characteristics. Here, CD274 is linked to breast carcinoma.